| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |